Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 588 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

GSK, Theravance submit UMEC NDA to FDA

UMEC/VI is a combination of two investigational bronchodilator molecules, GSK573719 or UMEC, a long-acting muscarinic antagonist (LAMA) and vilanterol, a long-acting beta2 agonist (LABA), administered using the ELLIPTA

Aphios receives NOA for oral delivery nanotechnology patent

The patent entitled ‘ Polymer Microspheres/Nanospheres and Encapsulating Therapeutic Proteins Therein’ covers the company’s oral delivery nanotechnology, designed for improving the oral bioavailability of macromolecules like insulin. Aphios

Ironwood Linzess drug available in US pharmacies

The FDA approved, once-daily, oral product is indicated for adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC). Linzess was designed to act locally

SSB to market Umetrics software portfolio globally

As part of the agreement, SSB will globally market and distribute complete Umetrics portfolio for the pharmaceutical and biopharmaceutical industries as well as integrate Umetrics software programs as